The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
At Memorial Sloan Kettering (MSK), we're not only changing the way we treat cancer, but also the way the world thinks about it. By working together and pushing forward with innovation and discovery, we're driving excellence and improving outcomes. We're treating cancer, one patient at a time. Join us and make a difference every day.
In compliance with applicable New York and New Jersey State regulatory authorities, COVID-19 vaccination (2 doses of either the Pfizer or Moderna vaccine or one dose of the Johnson & Johnson vaccine) is mandatory for all MSK employees, contingent workers, and volunteers. Exceptions are permitted for those employees who request and receive an approved medical or fully remote exemption.
*Staff working at a MSK New Jersey location must be up to date with COVID-19 vaccination, which includes having completed the primary COVID-19 vaccination series and booster once eligible as mandated by New Jersey State. All New Jersey staff not yet eligible for a booster must receive a booster within 3 weeks of becoming eligible as a condition of continued employment at MSK.
Note: Individuals are eligible to receive a COVID-19 booster five months after receiving the second dose of either the Pfizer or Moderna vaccine or two months after the J&J vaccine.
DIRECTOR, CENTER FOR CELL AND GENE THERAPY
The primary focus of the Director, Center for Cell and Gene Therapy will be to develop a coordinated institutional effort across clinical services, clinical labs and production facilities involved in transplantation and cell/gene therapy. At Memorial Sloan Kettering Cancer Center (MSKCC) there are currently over 700 bone marrow transplants (BMT), 5 autologous gene-transduced BMTs, and over 100 immune effector cell (IEC) infusions performed annually with significant expected growth over the next five years in both hematological malignancies and solid tumor. The mission of the Center for Cell and Gene Therapy will be to provide a unifying structure across the diverse activities supporting cell-based therapies at MSKCC in order to accelerate new developments and/or products into clinical trials. Additionally, the Center aims to better understand the immune environment resulting in the best outcomes for advanced cell/gene therapies. The Director will report to the Physician-in-Chief.
The Director will have the independence to shape the strategic and programmatic priorities of the Center, ensure clinical and operational excellence, including the rapid development of capacity for clinically relevant discovery through investigator-initiated trials, and the recruitment, professional development and retention of trainees and faculty within the Center.
The successful candidate will be an internationally recognized clinician-scientist with strong academic credentials and experience with the clinical care of hematologic malignancies and solid tumor patients with immune effector cells. In terms of the performance and personal competencies required for the position, we would highlight the following:
Collaboration and Influencing:
* Eager to partner with other MSKCC leaders to establish a multidisciplinary, coordinated framework for cell-based therapies
* Able to communicate and collaborate across different internal and external teams and stakeholders to influence and ensure support for initiatives
* Encourages others to share the spotlight and celebrate successes.
* Demonstrated ability to drive improvement and align a team.
* Particularly skilled at creating energy and commitment of others to engage in the change process, addressing concerns, and maintaining commitment through completion.
* Adept at instilling confidence in and commitment from the extended team, and senior leadership.
* A 'getting things done' mindset - a proven executor with the ability to manage multiple efforts simultaneously.
* Comfortable with ambiguity and uncertainty; the ability to adapt nimbly and lead others, through complex situations.
* An ability to balance the desire/need for broad change with an understanding of how much change the organization is capable of handling, creating realistic goals that are achievable and successful.
* An ability to persevere in the face of challenges and exhibit a steadfast resolve and commitment to higher standards, which commands respect from followers.
* An ability to outline transparent metrics for success and measure output with adjustments and course corrections as needed
* A leader who is viewed by others as having a high degree of integrity and credibility in their approach to making decisions.
* An ability to act in a transparent and consistent manner while always taking into account what is best for the organization.
* Leading by example and driving the organization's performance with an attitude of continuous improvement by being open to feedback and self-improvement.
Candidate Profile- Ideal Experience
At a minimum, qualified candidates should be/should have:
* Internationally recognized clinician as well as a leader in clinical, translational, laboratory based or population science.
* Extensive administrative experience
* Extensive knowledge of the clinical care of patients with Immune Effector Cells, with experience in both Hematologic Malignancy and Solid Tumor care.
* Board-eligible or board-certified in (Pediatric) Medical Oncology and/or Hematology
* Eligible for licensure in New York State and New Jersey
Nomination and Application Procedure
MSKCC has a strong commitment to enhancing the diversity of its faculty and staff. Applicants from diverse racial, ethnic, and cultural backgrounds are encouraged to apply. MSK offers competitive salaries and benefits. Interested applicants should send curriculum vitae and letter of interest to Valentina Salkow at firstname.lastname@example.org and Monchell Johnson at email@example.com
MSK is an equal opportunity and affirmative action employer committed to diversity and inclusion in all aspects of recruiting and employment. All qualified individuals are encouraged to apply and will receive consideration without regard to race, color, gender, gender identity or expression, sexual orientation, national origin, age, religion, creed, disability, veteran status or any other factor which cannot lawfully be used as a basis for an employment decision.
Federal law requires employers to provide reasonable accommodation to qualified individuals with disabilities. Please tell us if you require a reasonable accommodation to apply for a job or to perform your job. Examples of reasonable accommodation include making a change to the application process or work procedures, providing documents in an alternate format, using a sign language interpreter, or using specialized equipment.
At Memorial Sloan Kettering (MSK), we’re not only changing the way we treat cancer, but also the way the world thinks about it. By working together and pushing forward with innovation and discovery, we’re driving excellence and improving outcomes. For the 28th year, MSK has been named a top hospital for cancer by U.S. News & World Report. We are proud to be on Becker’s Healthcare list as one of the 150 Great Places to Work in Healthcare in 2018, as well as one of Glassdoor’s Employees’ Choice Best Place to Work for 2018. We’re treating cancer, one patient at a time. Join us and make a difference every day.